ClinicalTrials.gg
Enrolling by invitationNCT06591442Updated Sep 19, 2024

Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient

An observational study in Lumbar Disk Herniation, Lumbar Spinal Stenosis and Lumbar Spondylolisthesis, sponsored by Wuhan Union Hospital, China. Enrolling by invitation at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Wuhan Union Hospital, China · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Intervertebral Disc Displacement with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Intervertebral Disc Displacement · China.

Planned enrollment
3rd of 11
500 · median 120
Started
2024
with 6 others
Observational
11 of 52
4 open now
Primary completion
2027-09
later than 7 of 13 live
Registered
33rd of 52
by date

Among the 52 studies in Intervertebral Disc Displacement with a site in China, this one is the 3rd largest by planned enrollment of the 11 observational ones that give a count, is one of 7 that started in 2024, is one of 11 observational ones, reaches primary completion later than 7 of the 13 other live ones, and was the 33rd registered.

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.

Browse Intervertebral Disc Displacement studies →

Open to participants now

13 of the 52 studies in Intervertebral Disc Displacement with a site in China are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Intervertebral Disc Displacement with a site in China, or all of them as a file.
02

Study summary

To determine the high risk factors affecting accelerated recovery after spinal fusion surgery in advanced age patient.

Read the detailed description

To determine the high risk factors affecting accelerated recovery after spinal fusion surgery in elderly patients: a prospective cohort study

03

Conditions studied

  • Lumbar Disk Herniation
  • Lumbar Spinal Stenosis
  • Lumbar Spondylolisthesis
  • Cervical Spondylotic Myelopathy
  • Cervical Radiculopathy

Keywords

  • Enhanced recovery after surgery (ERAS)
  • Spinal fusion surgery
  • Advanced age patient
  • High risk factors
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Department of Orthopedics, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, China

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. signed and dated by subject or guardian
  2. Commit to follow the research procedures and cooperate with the whole process of the study
  3. The subjects are 60 years old or older, regardless of gender
  4. Patients with degenerative spinal diseases requiring spinal fusion surgery
  5. Generally in good physical condition
  6. Able to adhere to and cooperate with research interventions, such as oral medication
  7. In fertile women, should be used for at least one month prior to screening, and they should commit to use contraception throughout the study period and continue until the specified time after the study

Exclusion criteria

Exclusion Criteria:

  1. Acute infection
  2. Congenital malformation
  3. Abnormal anatomy or skeletal variation
  4. Malignant tumor
  5. The surgical area was locally infected with symptoms of local inflammation
  6. Fever or leukocytosis
  7. Morbid obesity
  8. Pregnant and nursing women
  9. Mental illness
  10. Acute joint disease, bone resorption, osteopenia and/or osteoporosis. Osteoporosis is a relative , as this condition may limit the degree of correction that can be produced, the amount of mechanical fixation, and/or the quality of the bone graft
  11. Patients who are unwilling to cooperate with post-operative treatment
  12. Any time an implant is performed it interferes with the anatomy or intended physiological function of the patient
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Elderly group patients (60-74 years).

    Diagnostic Test: This is an observational study

  • Advanced age group patients (≥75 years)

    Diagnostic Test: This is an observational study

Interventions

  • Diagnostic testThis is an observational study

    This study divides the elderly population into two groups: the Elderly group and the Advanced age group. By observing the enhanced recovery after spinal fusion surgery in these two distinct age groups of elderly patients, risk factors affecting postoperative enhanced recovery will be identified. Detection index: Blood routine examination, blood biochemistry, coagulation function, imaging examination (X-ray, CT 3D reconstruction), Japanese Orthopaedic Association (JOA) score, visual analogue scale (VAS) pain score. The number of participants for all adverse events, serious adverse events, implant-related adverse events and drug-related serious adverse events, and the adverse events were summarized accordingly. The severity of adverse events will be rated according to NCI-CTCAE version 4.0.

06

What researchers measure

Primary outcomes

  1. Safety Metrics for Enhanced Recovery After Spinal Fusion Surgery

    Blood routine examination, blood biochemistry, coagulation function, imaging examination (X-ray, CT 3D reconstruction). The number of participants for all adverse events, serious adverse events, implant-related adverse events and drug-related serious adverse events, and the adverse events were summarized accordingly. The severity of adverse events will be rated according to NCI-CTCAE version 4.0.

    Time frame: Baseline. 7 days, 3 months, 6 months, 9 months and 12 months after surgery

07

Study locations

1 site
  • Department of Orthopedics, Affiliated Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430023
    Wuhan, Hubei 430023, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Sep 2027, 36 months after the start.

Of 45 non-industry observational studies under Intervertebral Disc Displacement, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 69. This study's planned 36 months is above that.

Counting every sponsor, half of 49 studies reached it within 35 months; a quarter within 13 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 7, 2024
First posted
Sep 19, 2024
StartActual
Sep 3, 2024
Primary completionEst.
Sep 3, 2027
CompletionEst.
Sep 3, 2027
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06591442
Responsible party
Caoyang (Head of orthopedics; Professor, Wuhan Union Hospital, China) — Principal investigator
First posted
Sep 19, 2024
Start date
Sep 3, 2024
Primary completion
Sep 3, 2027 (estimated)
Completion
Sep 3, 2027 (estimated)
Last update
Sep 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion